Johnson & Johnson prepared to ship out 20M COVID-19 vaccines as it nears FDA authorization

Published



Pharmaceutical giant Johnson & Johnson is prepared to distribute 20 million doses of its single-shot vaccine to prevent COVID-19 if it wins regulatory authorization in the coming days.

“Assuming necessary regulatory approvals relating to our manufacturing processes, our plan is to begin shipping immediately upon emergency use authorization, and deliver enough single-doses by the end of March to enable the vaccination of more than 20 million Americans,” said Richard Nettles, Johnson & Johnson’s vice president of medical affairs for the company’s pharmaceutical division Janssen.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.